Term
6 indications for use of antidepressants in axiety disorders: |
|
Definition
1. OCD 2. Panic do 3. Social anxiety do 4. generalized anxiety 5. separation anxiety 6. PTSD |
|
|
Term
explain the lag time assoc w antidepressants and snxiety d/o's |
|
Definition
- 2-4wks or longer in generalixed anxiety - 8-12wks in panic d/o - >8wks in social anxiety (full benefit may not be seen until 12wks) |
|
|
Term
3 adverse effects of SSRIs: |
|
Definition
1. CNS - insomnia, akathisia (RLS), agitation 2. GI (N,V,D) 3. Sexual dysfunction |
|
|
Term
2 syndromes assoc w SSRIs: |
|
Definition
1. SSRI discontinuation syndrome: flu-like sx & electrical sensations 2. Serotonin syndrome: hyperthermia, myoclonus, Mental status changes, HTN |
|
|
Term
first line agent for generalized anxiety d/o: |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
1. panic disorder 2. generalized anxiety do |
|
|
Term
|
Definition
1. anticholinergic (constipation, dry mouth blurred vision) 2. sedation 3. weight gain 4. orthostatic hypotension 5. sexual dysfunction 6. potentially fatal in overdose |
|
|
Term
class of RX for clomipramine: |
|
Definition
|
|
Term
Clomipramine's role in therapy: |
|
Definition
useful for OCD as a second line behind SSRIs |
|
|
Term
|
Definition
|
|
Term
|
Definition
1. refractory panic d/o 2. 2nd line social anxiety 3. PTSD 4. insomnia, nightmares, flashbacks |
|
|
Term
|
Definition
1. interactions assoc w aged/fermented products 2. weight gain 3. CV effects |
|
|
Term
well tolerated and effective TETRAcyclic antidepressant for the tx of PTSD: |
|
Definition
|
|
Term
|
Definition
1. weight gain 2. drowsiness |
|
|
Term
BZO role in anxiety d/o's |
|
Definition
offer immediate relief - use when urgent response needed |
|
|
Term
BZO effect on generalized anxiety disorder: |
|
Definition
BZOs reduce somatic and autonomic sx but don't reduce xs worry |
|
|
Term
BZOs place in long term care for anxiety: |
|
Definition
use is short term (1-2wks) while waiting for other maintenence agents to kick in. |
|
|
Term
Rx that is the best choice for situational anxiety: |
|
Definition
|
|
Term
|
Definition
1. cognitive impairment 2. CNS depression 3. additive sedation w other sedatives 4. disinhibition 5. dependence/withdrawal |
|
|
Term
withdrawal sign/sx from BZO |
|
Definition
1. anxiety 2. insomnia 3. restlessness 4. agitation 5. muscle tension 6. irritability 7. seizures |
|
|
Term
|
Definition
1. valium 2. librium 3. klonopin 4. tranxene |
|
|
Term
|
Definition
1. serax 2. xanax 3. ativan |
|
|
Term
which is more likely to produce withdrawal sx, short or long acting BZOs? |
|
Definition
|
|
Term
role in therapy for busprione: |
|
Definition
for generalized anxiety disorders; non-habit forming/no withdrawal sx |
|
|
Term
|
Definition
|
|
Term
buspirone does not work for: |
|
Definition
1. depression 2. panic d/o 3. phobias 4. OCD |
|
|
Term
buspirone may require up to ___wks for effectiveness: |
|
Definition
|
|
Term
|
Definition
1. dizziness 2. nausea 3. HA 4. nervousness 5. dysphoria |
|
|
Term
agents worsening anxiety disorders: |
|
Definition
1. caffeine 2. stimulante meds (decongestants, ritalin) 3. diet teas 4. many herbal substances |
|
|
Term
4 "alternative agents" for the tx of anxiety: |
|
Definition
1. B-blockers 2. antihistamines 3. antipsychotics 4. moodstabilizers |
|
|
Term
first line therapy in PTSD |
|
Definition
mood stabilizers:VPA, carbemazepine, lithium |
|
|
Term
|
Definition
orthostaic hypotension and bradycardia |
|
|
Term
|
Definition
drowsiness, anticholinergic SE |
|
|
Term
antipsychotics role in anxiety therapy |
|
Definition
augmentation for refractory OCD & combined with other therapies n PTSD + psychosis, parinoia, hypervigilance |
|
|